Seminars in Nephrology
Volume 25, Issue 1 , Pages 43-49 , January 2005

Uric acid and chronic renal disease: Possible implication of hyperuricemia on progression of renal disease

  • Duk-Hee Kang

      Affiliations

    • Division of Nephrology, Ewha Women’s University College of Medicine, Ewha Medical Research Center, Seoul, Korea; and the Division of Nephrology, University of Florida, Gainesville, FL.
    • Corresponding Author InformationAddress reprint requests to Duk-Hee Kang, MD, Division of Nephrology, Ewha Women’s University College of Medicine, 70 Chongno 6-ka Chongno-ku Seoul 110-126, Korea.
  • ,
  • Takahiko Nakagawa

      Affiliations

    • Division of Nephrology, Ewha Women’s University College of Medicine, Ewha Medical Research Center, Seoul, Korea; and the Division of Nephrology, University of Florida, Gainesville, FL.

References 

  1. Ruilope LM , Garcia-Puig J . Hyperuricemia and renal function . Curr Hypertens Rep . 2001;3:197–202
  2. Elsayed NM , Nakashima JM , Postlethwait EM . Measurement of uric acid as a marker of oxygen tension in the lung . Arch Biochem Biophys . 1993;302:228–232
  3. Cannon PJ , Stason WB , Demartini FE , et al.   Hyperuricemia in primary and renal hypertension . N Engl J Med . 1966;275:457–464
  4. Wu X , Muzny DM , Lee CC , et al.   Two independent mutational events in the loss of urate oxidase during hominoid evolution . J Mol Evol . 1992;34:78–84
  5. Levinson DJ , Sorensen LB . Renal handling of uric acid in normal and gouty subject (Evidence for a 4-component system) . Ann Rheum Dis . 1980;39:173–179
  6. Maesaka JK , Fishbane S . Regulation of renal urate excretion (A critical review) . Am J Kidney Dis . 1998;32:917–933
  7. Enomoto A , Kimura H , Chairoungdua A , et al.   Molecular identification of a renal urate anion exchanger that regulates blood urate levels . Nature . 2002;417:447–452
  8. Roch-Ramel F , Guisan B , Diei J . Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles . J Pharmacol Exp Ther . 1997;280:839–845
  9. Lipkowitz MS , Leal-Pinto E , Rappoport JZ , et al.   Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter . J Clin Invest . 2001;107:1103–1115
  10. Martinez F , Manganel M , Montrose-Rafizadeh C , et al.   Transport of urate and p-aminohippurate in rabbit renal brush-border membranes . Am J Physiol . 1990;258:F1145–F1153
  11. Sica DA , Schoolwerth AC . Renal handling of organic anions and cations and renal excretion of uric acid . In:  Brenner B ,  Rector F editor. The Kidney . Philadelphia, PA: WB Saunders Company; 2000;p. 680–700
  12. Rieselbach RE , Steele TH . Intrinsic renal disease leading to abnormal urate excretion . Nephron . 1975;14:81–87
  13. Sorensen LB . Role of the intestinal tract in the elimination of uric acid . Arthritis Rheum . 1965;8:694–706
  14. Hatch M , Vaziri ND . Enhanced enteric excretion of urate in rats with chronic renal failure . Clin Sci (London) . 1994;86:511–516
  15. Talbott JH , Terplan KL . The kidney in gout . Medicine . 1960;39:405–450
  16. Tarng DC , Lin HY , Shyong ML , et al.   Renal function in gout patients . Am J Nephrol . 1995;15:31–37
  17. Gonick HC , Rubini ME , Gleason IO , et al.   The renal lesion in gout . Ann Intern Med . 1965;62:667–674
  18. Farebrother DA , Pincott JR , Simmons HA , et al.   Uric acid crystal-induced nephropathy (Evidence for a specific renal lesion in a gouty family) . J Pathol . 1981;135:159–168
  19. Farebrother DA , Hatfield PJ , Simonds HA , et al.   Acute intratubular crystal deposition causing permanent renal damage in the pig . Adv Exp Med Biol . 1974;41:523–534
  20. Klineberg JR , Gonick HC , Dornfield L . Renal function abnormalities in patients with asymptomatic hyperuricemia . Arthritis Rheum . 1975;18:725–730 (suppl)
  21. Kelton J , Kelley WN , Holmes EW . A rapid method for the diagnosis of acute uric acid nephropathy . Arch Intern Med . 1978;138:612–615
  22. Ribeiro RC , Pui CH . Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies . Clin Lymphoma . 2003;3:225–232
  23. Beck LH . Requiem for gouty nephropathy . Kidney Int . 1986;30:280–287
  24. Fessel WJ . Renal outcomes of gout and hyperuricemia . Am J Med . 1979;67:74–82
  25. Berger L , Yű T . Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies . Am J Med . 1975;59:605–613
  26. Yű T , Berger L , Dorph DJ , et al.   Renal function in gout. V. Factors influencing the renal hemodynamics . Am J Med . 1979;67:766–771
  27. Yű T , Berger L . Impaired renal function in gout. Its association with hypertensive vascular disease and intrinsic renal disease . Am J Med . 1982;72:95–100
  28. Rich M . Uric acid (Is it a risk factor for cardiovascular disease?) . Am J Cardiol . 2000;85:1018–1021
  29. Nickeliet V , Mihatsch MJ . Uric acid nephropathy and end-stage renal disease—review of a non-disease . Nephrol Dial Transplant . 1997;12:1832–1838
  30. Patial RK , Sehgal VK . Nonoliguric acute renal failure in gout . Indian J Med Sci . 1992;46:201–204
  31. Perez-Ruiz F , Calabozo M , Herrero-Beites AM , et al.   Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts . Nephron . 2000;86:287–291
  32. Rosenfeld JB . Effect of longterm allopurinol administration on serial GFR in normotensive and hypertensive hyperuricemic individuals . Adv Exp Biol Med . 1974;41B:581–596
  33. Hunsicker LG , Adler S , Caggiula A , et al.   Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study . Kidney Int . 1997;51:1908–1919
  34. Appel GB , Radhakrishnan J , Avram MM , et al.  the RENAAL Study   Analysis of metabolic parameters as predictors of risk in the RENAAL study . Diabetes Care . 2003;26:1402–1407
  35. Syrjänen J , Mustonen J , Pasternak A . Hypertriglyceridemia and hyperuricemia are risk factors for progression of IgA nephropathy . Nephrol Dial Transplant . 2000;15:34–42
  36. Ohno I , Hosoya T , Gomi H , et al.   Serum uric acid and renal prognosis in IgA nephropathy . Nephron . 2001;87:333–339
  37. Iseki K , Oshiro S , Tozawa M , et al.   Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects . Hypertens Res . 2001;24:691–697
  38. Tomita M , Mizuno S , Yamanaka H , et al.   Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers . J Epidemiol . 2000;10:403–409
  39. Mazzali M , Hughes J , Kim YG , et al.   Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism . Hypertension . 2001;38:1101–1106
  40. Mazzali M , Kanellis J , Han L , et al.   Hyperuricemia induces a primary arteriolopathy in rats by a blood pressure-independent mechanism . Am J Physiol . 2002;282:F991–F997
  41. Sanchez-Lozada LG , Tapia E , Avila-Casado C , et al.   Mild hyperuricemia induces glomerular hypertension in normal rats . Am J Physiol . 2002;283:F1105–F110
  42. Nakagawa T , Mazzali M , Kang DH , et al.   Hyperuricemia causes glomerular hypertrophy in the rat . Am J Nephrol . 2003;23:2–7
  43. Mazzali M , Kim Y-G , Suga S , et al.   Hyperuricemia exacerbates chronic cyclosporine nephropathy . Transplantation . 2001;71:900–905
  44. Kobelt V , Hess T , Matzkies F , et al.   Does allopurinol prevent side effects of cyclosporine-A treatment? . Transplant Proc . 2002;34:1425–1427
  45. Assis S , Moneteiro JL , Seguro AC . L-arginine and allopurinol protect against cyclosporine nephrotoxicity . Transplant . 1997;63:1070–1073
  46. Neal DAJ , Tom BDM , Gimson AES , et al.   Hyperuricemia, gout and renal function after liver transplantation . Transplantation . 2001;72:1689–1691
  47. Kang DH , Nakagawa T , Feng L , et al.   A role for uric acid in the progression of renal disease . J Am Soc Nephrol . 2002;13:2888–2897
  48. Kanellis J , Watanabe S , Li JH , et al.   Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2 . Hypertension . 2003;41:1287–1293
  49. Newland H . Hyperuricemia in coronary, cerebral and peripheral arterial disease (An explanation) . Med Hypotheses . 1975;1:152–155
  50. Rao GN , Corson MA , Berk BC . Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet derived growth factor A-chain expression . J Biol Chem . 1991;266:8604–8608
  51. Young W , Mahboubi K , Haider A , et al.   Cyclooxygenase-2 is required for tumor necrosis factor-alpha and angiotensin II-mediated proliferation of vascular smooth muscle cells . Circ Res . 2000;86:906–914
  52. Kang DH , Kim GM , Yu ES , et al.   Uric acid induces C-reactive protein expression via differential regulation of angiotensin II receptors and angiotensin converting enzyme in vascular endothelial and smooth muscle cells . J Am Soc Nephrol . 2003;14:136A; (abstr)
  53. Bagnati M , Perugini C , Cau C , et al.   When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation (A study using uric acid) . J Biochem . 1999;340:143–152
  54. Ames BN , Cathcart R , Schwiers E , et al.   Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer (A hypothesis) . Proc Natl Acad Sci U S A . 1981;78:6858–6862
  55. Alderman MH , Cohen H , Madhavan S , et al.   Serum uric acid and cardiovascular events in successfully treated hypertensive patients . Hypertension . 1999;34:144–150
  56. Hsu SP , Pai MF , Peng YS , et al.   Serum uric acid levels show a ’j-shaped’ association with all-cause mortality in haemodialysis patients . Nephrol Dial Transplant . 2004;19:457–462
  57. Kang DH , Seoh JY , Yoon KI . A possible link between hyperuricemia and systemic inflammatory reaction as a mechanism of endothelial dysfunction in chronic renal failure . J Am Soc Nephrol . 2002;13:466; (abstr)

 Supported by grant R04-2002-000-00183-0 from the Basic Research Program of the Korea Science and Engineering Foundation (D.-H.K.).

PII: S0270-9295(04)00191-3

doi: 10.1016/j.semnephrol.2004.10.001

Seminars in Nephrology
Volume 25, Issue 1 , Pages 43-49 , January 2005